在快速化学重编程的细胞命运过渡过程中解读替代拼接模式
Yunkun Lu1,2, Kainan Lin3, Yeling Ruan4
1Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China. kevenloo1@zju.edu.cn.
BMC biology
|June 9, 2025
概括
快速化学重编程 (FCR) 在细胞命运过渡过程中揭示了动态替代拼接 (AS) 模式. 外基因排斥占主导地位,Ptbp3被确定为影响表观遗传调节的关键拼接因子.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 细胞生物学 细胞生物学
背景情况:
- 替代拼接 (AS) 在真核生物中显著增加了转录组复杂性.
- 快速化学重编程 (FCR) 为快速的体细胞转化为诱导多能干细胞 (iPSC) 提供了一种新的方法.
研究的目的:
- 研究由快速化学重编程 (FCR) 系统诱导的细胞命运过渡过程中的替代拼接 (AS) 的动态.
- 了解FCR期间基因表达和AS模式之间的相互作用.
- 为了比较FCR和转录因子诱导的重编程 (TFR) 之间的AS模式.
主要方法:
- 利用FCR系统诱导细胞命运过渡.
- 分析了基因表达特征,以描述FCR轨迹.
- 检查了替代拼接模式,包括外子包含/排除和内子保留事件.
主要成果:
- 基于基因表达的FCR轨迹与观察到的AS模式相关,表明了调控相互作用.
- 在FCR期间,外子排除比外子纳入更为普遍.
- 与TFR相比,FCR表现出不同的AS模式,突出了系统特定的监管.
- 聚皮里米丁管结合蛋白3 (Ptbp3) 被确定为参与后期表观遗传调节的潜在拼接因子.
- 结合体活性下降导致了内质保留,可能会降低与隔膜关联的基因的调节.
结论:
- 在FCR期间提供了AS的详细描述,强调其在细胞命运调节中的关键作用.
- 对控制细胞命运决策的分子机制的高级理解.
- 提供了关于FCR在再生医学和治疗应用中的潜力的见解.
相关概念视频
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


